Access to anti-retroviral drugs, female (%) in Venezuela
Venezuela: Access to anti-retroviral drugs, female (%) was 54.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Venezuela, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Venezuela stood at 54.0%.
That represents a change of up 8.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Venezuela peaked at 64.0% in 2015 and was at its lowest, 3.0%, in 2000.
Venezuela ranks 114th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female (%) in Venezuela, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 3.0% | — |
| 2001 | 7.0% | +133.3% |
| 2002 | 10.0% | +42.9% |
| 2003 | 11.0% | +10.0% |
| 2004 | 13.0% | +18.2% |
| 2005 | 14.0% | +7.7% |
| 2006 | 23.0% | +64.3% |
| 2007 | 27.0% | +17.4% |
| 2008 | 33.0% | +22.2% |
| 2009 | 39.0% | +18.2% |
| 2010 | 46.0% | +17.9% |
| 2011 | 49.0% | +6.5% |
| 2012 | 51.0% | +4.1% |
| 2013 | 50.0% | -2.0% |
| 2014 | 50.0% | +0.0% |
| 2015 | 64.0% | +28.0% |
| 2016 | 57.0% | -10.9% |
| 2017 | 44.0% | -22.8% |
| 2018 | 35.0% | -20.5% |
| 2019 | 46.0% | +31.4% |
| 2020 | 53.0% | +15.2% |
| 2021 | 54.0% | +1.9% |
| 2024 | 54.0% | +0.0% |
Venezuela compared with similar countries
- Venezuela's 54.0% is below the median for lower middle income countries, which is 80.0%, 68% of the median. (39 countries reporting)
- Venezuela's 54.0% is below the median for Latin America & Caribbean, which is 68.0%, 79% of the median. (23 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female (%) in Venezuela changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2001 | +133.3% | 3.0% | 7.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 18.0% | 3.0% | 39.0% | 10 |
| 2010s | 49.2% | 35.0% | 64.0% | 10 |
| 2020s | 53.7% | 53.0% | 54.0% | 3 |
Countries ranked near Venezuela
More gender data for Venezuela
- Child population (UN estimates and projections) 6,517 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.32 % change on previous year (2030)
- Population 22,635 (2030)
- Working-age population (UN estimates and projections) 22,635 (2030)
- Population (UN estimates and projections), annual growth rate 1 % change on previous year (2030)
- Age population, age 00, female, interpolated 207,912 (2025)
- Age population, age 00, male, interpolated 218,340 (2025)
- Age population, age 01, female, interpolated 204,155 (2025)
- Age population, age 01, male, interpolated 214,388 (2025)
- Age population, age 02, female, interpolated 200,986 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Venezuela?
- Access to anti-retroviral drugs, female in Venezuela was 54.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Venezuela?
- The highest recorded value was 64.0% in 2015.
- What is the lowest access to anti-retroviral drugs, female recorded in Venezuela?
- The lowest recorded value was 3.0% in 2000.
- How does Venezuela rank for access to anti-retroviral drugs, female?
- Venezuela ranks 114th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Venezuela?
- Over the last ten years it is up 8.0%. The long-run trend across the full record is volatile.
- Where does this Venezuela data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.